1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Short-acting β2-agonist use and asthma exacerbations in Swedish children : A SABINA Junior study
(
- Contribution to journal › Article
- 2020
-
Mark
Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality : A nationwide cohort study of the global SABINA programme
(
- Contribution to journal › Article